Evidence map›Paper›PMID 38487965›Full record

ArticleCancer communications (London, England)2024

Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study.

Anna Jansana, Aviane Auguste, Marina Kvaskoff, Agnès Fournier, Emma Fontvieille, Laia Peruchet-Noray, Carine Biessy, Reynalda Cordova, Kristina Elin Nielsen Petersen, Anne Tjønneland and 16 more

Abstract readLetterMulticenter Study
In one paragraph

Article in Cancer communications (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Anna JansanaInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.ORCID 0000-0001-8504-1618
Aviane AugusteParis-Saclay University, University of Versailles-Saint-Quentin-en-Yveline, University Paris-Sud, French National Institute for Health and Medical Research (Inserm), Gustave Roussy, "Exposome and Heredity" Team, CESP, Villejuif, France.
Marina KvaskoffParis-Saclay University, University of Versailles-Saint-Quentin-en-Yveline, University Paris-Sud, French National Institute for Health and Medical Research (Inserm), Gustave Roussy, "Exposome and Heredity" Team, CESP, Villejuif, France.
Agnès FournierParis-Saclay University, University of Versailles-Saint-Quentin-en-Yveline, University Paris-Sud, French National Institute for Health and Medical Research (Inserm), Gustave Roussy, "Exposome and Heredity" Team, CESP, Villejuif, France.
Emma FontvieilleInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Laia Peruchet-NorayInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Carine BiessyInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Reynalda CordovaInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Kristina Elin Nielsen PetersenDanish Cancer Society Research Center, Copenhagen, Denmark.
Anne TjønnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Verena KatzkeDivision of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
Fulvio RicceriDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Salvatore PanicoDepartment of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Paolo ContieroEnvironmental Epidemiology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)-Istituto Nazionale dei Tumori, Milan, Italy.
Maria-Jose SánchezCancer Registry of Granada, Institute for Biosanitary Research of Granada (ibs.GRANADA), Granada, Spain.
Jesus CastillaEpidemiology and Control of Chronic Diseases Group, Epidemiology and Public Health Networking Biomedical Research Centre, Madrid, Spain.
Marta Crous-BouUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Alicia HeathDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, UK.
Elom Kouassivi AglagoDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, UK.
Elisabete WeiderpassInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Marc James GunterInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Pietro FerrariInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, UK.
Vivian ViallonInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Heinz FreislingInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.

Funding

Cancéropôle Ile-de-France N°2018-1-PLSHS-06-CIRC-1Cancer Research UK 14136French National Cancer Institute INCA_N°2018-123Medical Research CouncilWorld Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neoplasm MetastasisAdultAgedCardiovascular DiseasesFemaleHumansMaleMetabolic SyndromeMiddle AgedNeoplasmsNeoplasm StagingProspective Studies

Identifiers

PMID38487965
PMCPMC11110950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.